(Reuters) - Pacira Pharmaceuticals Inc said a late-stage study showed the painkiller, Exparel, significantly reduced pain for a wider range of patients after surgery, sending its shares up 5 percent in premarket trading. This expands the use of the drug to cases where it is difficult to inject a painkiller directly into the area of pain.
via Health News Headlines - Yahoo News http://ift.tt/1mG7diY
via Health News Headlines - Yahoo News http://ift.tt/1mG7diY
No comments:
Post a Comment